Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03380 |
| Species: | Homo sapiens |
| Position : | chr6:31130000-31131000 |
| Year: | 2022 |
| Title: | Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer-promoter interactions. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cervical cancer |
| PMID: | 35849129 |
| MONDO: | MONDO:0002974 |
| Tissue: | uterine cervix |
| Tissue Ontology ID: | UBERON:0000002 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Functional perturbation assay |
| Low Throughput Method: | CRISPR Knockout; CRISPRi; RT-RT-qPCR |
| Target gene : | POU5F1 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|